Jack Syage
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jack Syage
Jack Syage is recorded as CTO, COO and Board Member at GridAI Technologies Corp. (GRDX). GridAI Technologies Corp. reported in an 8-K filed June 20, 2024 that Jack Syage was appointed Chief Scientific Officer, effective June 17, 2024. GridAI Technologies Corp. reported in an 8-K filed March 14, 2024 that Jack Syage was appointed board of directors, effective March 14, 2024. GridAI Technologies Corp. reported in an 8-K filed March 14, 2024 that Jack Syage was appointed member of the Board, effective March 13, 2024. Equibles holds 4 filed executive changes naming Jack Syage; each is listed under recent activity with its source filing.
“On June 17, 2024, the Board of Directors (the "Board") of Entero Therapeutics, Inc. (the "Company"), after discussions with Jack Syage, the Company's President, Chief Operating Officer and a member of the Board, transitioned Dr. Syage from the role of Chief Operating Officer to the newly appointed role of Chief Scientific Officer, effective immediately.”
“Dr. Syage and Dr. Chaitan Khosla will also join the board of directors of First Wave BioPharma.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-17–present
-
Current
2024-03-13–present
-
Current
2024-03-13–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at GridAI Technologies Corp.
Other people whose current roles at this company are on record from its filings.
- Jason D. Sawyer CEO
- Richard Joel Paolone CEO, Chairman, Board Member
- Anna Skowron CFO
- Daniel Schneiderman CFO
- Jack Syage, PhD. COO
- Alastair Riddell Board Member
- Alson Niu Board Member
- Chaitan Khosla Board Member
- David Hoffman Board Member
- Edward J. Borkowski Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.